Two year follow-up study shows that re-treatment with Radium-223 from @BayerPharma is well tolerated in patients with CRPC metastatic to bone. #EAU18
Two year follow-up study shows that re-treatment with Radium-223 from @BayerPharma is well tolerated in patients with CRPC metastatic to bone. #EAU18